(Q34714875)

4 August 2017

1 reference

title

Immunologic aspects of tropical lung disease (English)

1 reference

4 August 2017

1

1 reference

4 August 2017

D Geraint James

2

1 reference

4 August 2017

1 June 2002

1 reference

Clinics in Chest Medicine

4 August 2017

1 reference

4 August 2017

23

1 reference

4 August 2017

2

1 reference

4 August 2017

283-308, vii

1 reference

Etiology of childhood community acquired pneumonia and its implications for vaccination

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Defense mechanisms against infections

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Host defenses and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Current concepts on pulmonary host defense mechanisms in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Mucosal immunity in the lung and upper airway

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Innate immunity and pulmonary host defense

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

The neutrophil: function and regulation in innate and humoral immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Entry and survival of pathogenic mycobacteria in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Eosinophils in asthma and other allergic diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Pulmonary T cells and eosinophils: coconspirators or independent triggers of allergic respiratory pathology?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Dendritic cells as sensors of infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Characterization of dendritic cell populations in the respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Natural killer cells and the syndrome of chronic natural killer cell lymphocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

The many faces of host responses to tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Leishmania, macrophages and complement: a tale of subversion and exploitation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

The immunology of malaria infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Surfactant regulation of host defense function in the lung: a question of balance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Pulmonary collectins and innate host defense of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Hepatic response to sepsis: interaction between coagulation and inflammatory processes.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

The inflammatory response in humans after inhalation of bacterial endotoxin: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

III. Chemokines and other mediators, 8. Chemokines and their receptors in cell-mediated immune responses in the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Complement. First of two parts

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Complement. Second of two parts

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Complement resistance of parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Th1/Th2 lymphocyte polarization in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Immunologic mechanisms in granulomatous lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Parasite immune evasion and exploitation: reflections and projections

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Molecular basis for evasion of host immunity and pathogenesis in malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Defence against the immune barrage: helminth survival strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Multiple mechanisms of immune evasion by African trypanosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

The immune response to Leishmania: mechanisms of parasite control and evasion.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Concomitant infections, parasites and immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Superantigens, T cells, and microbes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Microbes and microbial Toxins: paradigms for microbial-mucosal toxins. V. Cholera: invasion of the intestinal epithelial barrier by a stably folded protein toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Nutritional factors and cellular immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Nutrition and development of pulmonary defense mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

HIV and pulmonary immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Humoral immune response within the lung in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Approach to the diagnosis of pulmonary disease in patients infected with the human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Pneumocystis carinii pneumonia in Malawian children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Disease in children infected with HIV in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Immune deviation as a strategy for schistosomiasis vaccines designed to prevent infection and egg-induced immunopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Elevated IL-5 levels in pleural fluid of patients with paragonimiasis westermani

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Infection due to Strongyloides stercoralis in patients with pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Disseminated Strongyloides stercoralis in human immunodeficiency virus-infected patients. Treatment failure and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Bacterial complications of strongyloidiasis: Streptococcus bovis meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Human toxocariasis and the visceral larva migrans syndrome: correlative immunopathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Case report: fulminant Toxoplasma gondii pneumonia in a patient with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Pulmonary toxoplasmosis in patients infected with human immunodeficiency virus: a French National Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Autopsy findings in the acquired immunodeficiency syndrome (AIDS). A report of 395 cases from the south of France

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Pulmonary malignancies in the immunocompromised patient

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Family size, infection and atopy: the first decade of the "hygiene hypothesis".

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Atopy in children of families with an anthroposophic lifestyle.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

The inverse association between tuberculin responses and atopic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Vaccines for the developing world: current status and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Progress toward a malaria vaccine: efficient induction of protective anti-malaria immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

Novel nonantibiotic therapies for pneumonia: cytokines and host defense

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2801%2900005-3

7 January 2021

10.1016/S0272-5231(01)00005-3

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12092026